These observations emphasize the impact of each single single-base-sequence alterations may have on the tumor suppressor LATS1 gene expression in cancer, as well as the contribution of these SNPs/variants in LATS1 inactivation and the subsequent increased risk of urinary bladder and colon malignancies. This evidence concerns the gene LATS1 and cancer.